
MonitHer ‘s New Home-Use Breast Cancer Detection Device Wins WeWork’s $360 K Creator Award
While Yehudit Abrams was working as a postdoctoral fellow at NASA, her job was to research the potential use of ultrasound to monitor astronauts on

Analytics Insights Selected BrainQ as One of the 10 Most Innovative Artificial Intelligence Solution Providers for 2018
Analytics Insight announced in their June digital magazine of that BrainQ is one of the most Innovative AI solution providers for 2018. Analytics Insight is

Lab-Made Meat Startup SuperMeat raises $3M Seed to develop ‘Clean’ Chicken
SuperMeat, an Israeli biotech and food-tech startup that is developing lab-made chicken meat, raised early this year $3 million in seed funding, as it becomes

Cellect Signs Strategic Agreement with Swiss Biotech Center (SBC) & with Dresden University denovoMATRIX Team
Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell production technology, announced that it has entered into a strategic manufacturing and supply agreement

Oramed to be Added to Russell Microcap® Index
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it

Prince William Experiences Orcam’s Life Changing Device for Blind People
Prince William, the Duke of Cambridge, has made a truly historic first official visit of a member of the Royal Family to Israel. Yesterday, June

Mazor Robotics’ Renaissance System installed at Georgia ASC and at Advocate Lutheran General Hospital in Illinois
In June 2018, GNS Surgery Center, an affiliate of United Surgical Partners International, announced that it has completed their first procedure with the Mazor Robotics

Jerusalem based Entera Bio Ltd. Announces Pricing of IPO for conducting Clinical Trials of Three Orally delivered Drugs targeting the Gastrointestinal Tract
Entera Bio Ltd. (NASDAQ:ENTX) (NASDAQ:ENTXW), a clinical-stage biopharmaceutical company focused on the development and commercialization of orally delivered large molecule therapeutics and is conducting clinical
Kadimastem has Upgraded its Manufacturing Site for Treatment of ALS Patients in the Clinical Trial
Kadimastem chose to upgrade the production rooms, for the treatment of ALS patients in the Phase 1 / 2a clinical trial, and adapt them to